Need for Mass Hepatitis A Vaccination of Indian Children – (10-24-02)

Need for Mass Hepatitis A Vaccination of Indian Children

Hmmm….a worldwide organization suggesting that Hep A vaccine is unnecessary because most children have antibodies to the virus by age 10. And yet, here in the US, we are pushing hard to vaccinate everyone against Hep A (and B for that matter…just to ensure that those tiny little IV drug users don’t get exposed via their sexual promiscuity…). Does this seem contradictory? We need to realize that our children are being USED in an attempt to prevent Hep A in adults. The vaccination has nothing to do with preventing the disease in children. In children the disease is hardly noticeable and self limiting. The truth would be nice for our parents–then let them decide if they still want their kids vaccinated.

Read entire article here

Bulletin of the World Health Organization 2002;80:728-731.

There may not be a need for universal vaccination of Indian children against hepatitis A, as a vast majority develop protective antibodies by 10 years of age, researchers from India report in the September Bulletin of the World Health Organization. Improvement in standards of living has led to a decreased prevalence of protective antibodies among children in various parts of the world. The result is an increased predisposition to severe forms of hepatitis A, but this mainly occurs in adults, Dr. Yogesh Batra and colleagues from the All India Institute of Medical Sciences in Delhi note. The paucity of specific data on hepatitis A seroprevalence in Indian children prompted the investigators to undertake a study of 500 school children between the ages of 10 and 17 years. The researchers tested for anti-hepatitis A antibodies using enzyme-linked immuno-sorbent assay (ELISA). A detailed clinical and biochemical evaluation was also conducted. Antibodies to hepatitis A were detected in 486 children (97.2%), indicating exposure to the virus, the researchers report. Anti-hepatitis A seroprevalence was 98.6% in children aged 10-12 years, 94.8% in children aged 13-14 years and 98.3% in children aged 15-17 years. There was no difference in anti-hepatitis A seroprevalence between boys and girls, Dr. Batra and colleagues report. A decline in the anti-hepatitis A seroprevalence among children is likely to result in an increase in incidence of hepatitis A infection among adults, Dr. Batra and colleagues warn. However, the incidence of hepatitis A in their hospital has more or less remained static between 1992 and 2000, so it is likely that anti-hepatitis A seroprevalence has changed little over the same period, the investigators believe. Similar results have been noted in other developing countries, where improvements in living conditions have not translated into a decline in the anti-hepatitis A seroprevalence, Dr. Batra comments. Thus, in endemic countries like India, where “exposure to hepatitis A virus is virtually universal” among children and the incidence of hepatitis A infection among adults has remained static, “mass vaccination against hepatitis A virus may not be cost-effective” or necessary, the Delhi team asserts.


James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.